Attached files

file filename
EX-10.11 - EX-10.11 - SUPERNUS PHARMACEUTICALS, INC.supn-20201231xex1011.htm
EX-32.2 - EX-32.2 - SUPERNUS PHARMACEUTICALS, INC.supn-20201231xex322.htm
EX-32.1 - EX-32.1 - SUPERNUS PHARMACEUTICALS, INC.supn-20201231xex321.htm
EX-31.2 - EX-31.2 - SUPERNUS PHARMACEUTICALS, INC.supn-20201231xex312.htm
EX-31.1 - EX-31.1 - SUPERNUS PHARMACEUTICALS, INC.supn-20201231xex311.htm
EX-23.1 - EX-23.1 - SUPERNUS PHARMACEUTICALS, INC.supn-20201231xex231.htm
EX-10.12 - EX-10.12 - SUPERNUS PHARMACEUTICALS, INC.supn-20201231xex1012.htm
EX-10.10 - EX-10.10 - SUPERNUS PHARMACEUTICALS, INC.supn-20201231xex1010.htm
EX-10.9 - EX-10.9 - SUPERNUS PHARMACEUTICALS, INC.supn-20201231xex109.htm
10-K - 10-K - SUPERNUS PHARMACEUTICALS, INC.supn-20201231.htm

EXHIBIT 21 

SUBSIDIARIES OF SUPERNUS PHARMACEUTICALS, INC.


Name of SubsidiariesJurisdiction of Organization
MDD US Enterprises, LLCDelaware
MDD US Operations, LLCDelaware
Supernus Europe Ltd. United Kingdom
Biscayne Neurotherapeutics, Inc.Delaware